Delivery Order SPE2DB24D1021-SPE2DB25FEVWE
Award Date
4/11/25
Potential Completion Date
4/14/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,547.13, is for the delivery of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 8, 2025. There is no set-aside designation for this contract. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,542.20, is for the supply of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product. The contract has a completion date of February 25, 2025 and is a firm fixed-price delivery order. There is no set-aside designation indicated for this award. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,345.79 firm fixed-price delivery order contract, with a completion date of January 8, 2025, is for the supply of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This is a $3,959.78 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a medical product, with a period of performance through November 8, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a $1,566.91 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, which has no set-aside designation, is for the supply of the medication MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,295.88 firm fixed-price delivery order contract is for the pharmaceutical product MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, with an ultimate completion date of October 27, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MYFEMBREE, a specialty medication, and has a ceiling value of $1,632.41. The contract is a firm fixed-price Indefinite Delivery Vehicle (IDV) with a period of performance through January 2025. The contract is not designated as a set-aside and was awarded through open competition....
This federal contract award, valued at $4,466.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S medical products. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This is a $3,891.46 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract is to provide MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, which are likely specialty pharmaceutical products, to support military healthcare programs. The award does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,480.80, is a delivery order for the pharmaceutical product MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S. The contract has a firm fixed price and an ultimate completion date of February 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...